JC
TECX

JBF Capital’s Tectonic Therapeutic TECX Stock Holding History

JBF Capital’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,333
Closed -$218K – 78
2023
Q4 		$218K Hold
13,333
– – 0.04% 65
2023
Q3 		$246K Buy
+13,333
New +$236K 0.05% 58

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JBF Capital's TECX Position: Q1 2024 in Review

JBF Capital sold out of Tectonic Therapeutic (TECX) in Q1 2024, closing a stake of 13,333 shares — an estimated $218K sold.

JBF Capital first reported a position in TECX in Q3 2023 and held it in 2 quarters. The position peaked at $246K in Q3 2023. 46 funds tracked by Wall St. Rank hold TECX as of Q1 2024.

  • JBF Capital reported no remaining Tectonic Therapeutic position as of Q1 2024 after selling out during the quarter.
  • JBF Capital sold 13,333 Tectonic Therapeutic shares in Q1 2024, an estimated $218K.
  • JBF Capital first reported a position in Tectonic Therapeutic in Q3 2023 and held it in 2 quarters.
  • JBF Capital's Tectonic Therapeutic position peaked at $246K in Q3 2023.
  • 46 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2024.

Based on JBF Capital's 13F filing for Q1 2024, filed 14 May 2024.